Promoting Appropriate Weight Gain Pregnant Women (GRUVE)

July 31, 2024 updated by: University of Kansas Medical Center
The purpose of this study is to learn if engaging in group based phone counseling (GBPC) and an interactive physical activity monitoring system can help pregnant women gain an appropriate amount of weight during pregnancy.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 12-16 weeks pregnant
  • Pre-pregnancy BMI between 22 kg/m2 to 45 kg/m2

Exclusion Criteria:

  • Diabetes
  • Pre-eclampsia
  • Hypertension
  • Other metabolic abnormalities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Arm
Participants in this group were informed to continue to receive usual care.
Experimental: Intervention Arm
Received an interactive physical activity monitoring system (the Gruve®).
Participants received a interactive physical activity monitoring system that allowed study personnel to monitor their activity level.
Experimental: Intervention Arm 2
Received an interactive physical activity monitoring system (the Gruve®) and group based phone counseling (GBPC).
Participants received an interactive physical activity monitoring system, an electronic scale to report weekly body weight, weekly hour long conference calls with structured interactive educational lessons led by Health Educator, dietary recalls were completed at three different time points during their participation, and study personnel monitored physical activity levels weekly.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Excessive gestational weight gain
Time Frame: During Pregnancy - 18-36 week gestational age
Proportion of excessive gestational weight gain based on weight gain guidelines.
During Pregnancy - 18-36 week gestational age

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gestational weight gain
Time Frame: During Pregnancy - 18-36 week gestational age
Total weight change during pregnancy
During Pregnancy - 18-36 week gestational age
Infant fat mass
Time Frame: 1-4 days after birth
Infant fat mass
1-4 days after birth

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Holly R Hull, PhD, The University of Kansas Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 26, 2013

Primary Completion (Actual)

December 16, 2015

Study Completion (Actual)

February 3, 2016

Study Registration Dates

First Submitted

November 14, 2019

First Submitted That Met QC Criteria

November 25, 2019

First Posted (Actual)

November 29, 2019

Study Record Updates

Last Update Posted (Actual)

August 2, 2024

Last Update Submitted That Met QC Criteria

July 31, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 13749

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy

Clinical Trials on Intervention

Subscribe